Raymond W. Nims
Raymond Nims has more than 37 years of experience in the biomedical sciences. He currently provides consulting services as an employee of RMC Pharmaceutical Solutions. From 2006 to 2009, Dr. Nims served in Amgen’s corporate quality control group, providing subject matter expertise in viral and mycoplasma testing of raw materials and products, and serving as business process owner for Amgen’s global contract analytical testing lab outsourcing program. From 1994 to 2006, he directed laboratories at BioReliance, performing viral safety, endotoxin, and cell-line identity studies for biologics cell-line characterization, raw material testing, and product lot release testing. From 1985 to 1994, he served as a chemist at the National Cancer Institute’s Laboratory of Chemical Carcinogenesis. Dr. Nims obtained a Ph.D. in Chemistry (Chemical Toxicology) at The American University, Washington, DC, in 1993. He currently serves on the editorial board for BioProcessing Journal and has served on the ad hoc advisory boards for USP chapters 1237, 1050, and 1050.1. He is a generalist in the biomedical sciences, with a publication list spanning a wide range of topics in chemistry, carcinogenesis, biochemistry, pharmacology, toxicology, and virology.